Actualités de Dublin
- plus
GH Research Ltd. Announces Completion of Phase 1 Clinical Study with GH001 (5-Methoxy-N,N-Dimethyltryptamine) in Healthy Volunteers and Updates on Further Progress
plusMagnostics is Co-Developing and Launching a Viral RNA Extraction Kit for Medium Throughput Processing of COVID-19 Samples for Detection Using RT-PCR
plusAvectas Opens Canadian Development Site
plusChirisa divests 365 Data Centers
plusAvectas and UC Davis Collaborate on Cell Engineering Technology
plusAvectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office
plusOrion Novotus Selects Saba to Power Its Recruitment Outsourcing Strategy
plusKellogg Invests EUR110 Million in Pringles Factory Expansion
plusSaba Software Completes Acquisition of Lumesse
plusSaba Software Announces Agreement to Acquire Lumesse, Accelerating Its Global Leadership in Talent Development
plusCisco Provides 'Project-Based Challenges' for Participants in Skills Training With Digital Skills Academy
plusDigital Skills Academy Says Time is Running Out for Those Yet to Digitally Upskill
plusDigital Skills Academy Answers Industry's Call for Improved Digital Training
plusAmsterdam Court Clears Way for Pan-European Truck Cartel Damages Claim; Scania Fined EUR880m by European Commission
plusShire Pharmaceuticals Group Plc
The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis
plusAllergan Launches Juvéderm® VOLITE - An Innovative Injectable Treatment Designed to Improve Skin Quality for up to 9 Months
plusDS Biopharma (DS) Announces that Recruitment has Begun in Two Separate Phase 2b Atopic Dermatitis Studies with Lead Compound DS107 as well as the Successful Completion of a Phase 1 trial for Follow on Compound DS109
plusSMBC Aviation Capital Closes $500 Million Senior Unsecured Notes Offering and Announces Financial Results for the Fiscal Year Ended 31 March 2016
plusShire Pharmaceuticals Group Plc
Shire plc ("Shire") Publication of Circular, Notice of General Meeting and Prospectus and Directorate Change
plusShire Pharmaceuticals Group Plc
Developments to Income Access Share Arrangements - Elections for the Interim Dividend in Respect of the Six Months to December 31, 2015
plusFenergo Works With Markit and kyc.com to Deliver Enhanced Client Lifecycle Management for Financial Institutions
plusBaxalta Incorporated and Shire plc
Shire to Combine with Baxalta, Creating the Global Leader in Rare Diseases
plusJJ Abrams Sought the Authenticity of Skellig Michael for Star Wars - The Force Awakens
plusIn a Galaxy Not So Far Away... Ireland Feels 'The Force'
plusSunTrust Robinson Humphrey Streamlines Entity Data and Client Lifecycle Management with Fenergo
plusFenergo Launches Fenergo Data Integration Manager to Create a Single Client View for Client Lifecycle Management
plusAllergan to Acquire earFold(TM), an Innovative Medical Device for the Correction of Prominent Ears
plusShire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
plusTesla and Gaelectric to Introduce Tesla Battery Storage to Ireland
plus
12Suivant